IAMS WEALTH MANAGEMENT, LLC

Position in ABBV — AbbVie Inc.

CIK 1998182 OMAHA, NE

Position in ABBV

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$836,451

+$213,560 QoQ

Shares Held

3,324

+16.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#2,713

of 4,153 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

IAMS WEALTH MANAGEMENT, LLC holds $8,450,725 across 5 Drug Manufacturers - General names. ABBV ranks #4 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	25,186	$3,181,999
2	AZN	Astrazeneca PLC	10,885	$2,064,013
3	JNJ	Johnson & Johnson	6,777	$1,721,154
4	ABBV	AbbVie Inc. This page	3,324	$836,451
5	AMGN	Amgen Inc	1,787	$647,108

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$836,451	3,324	+16.1%	Shares	Sole	2026-07-16
2026-03-31	$622,891	2,864	+72.4%	Shares	Sole	2026-04-15
2025-12-31	$379,521	1,661	-4.8%	Shares	Sole	2026-01-26
2025-09-30	$404,037	1,745	—	Shares	Sole	2025-10-15
No filing history on record for this holder in this stock.